HARBINGER Trademark

Trademark Overview

On Thursday, August 6, 2020, a trademark application was filed for HARBINGER with the United States Patent and Trademark Office. The USPTO has given the HARBINGER trademark a serial number of 90096927. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, December 19, 2023. This trademark is owned by Flagship Labs 66, Inc.. The HARBINGER trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits and preparations for use in the treatment and diagnosis of cancer

Diagnostic services for use in the treatment and diagnosis of cancer

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
harbinger

General Information

Serial Number90096927
Word MarkHARBINGER
Filing DateThursday, August 6, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, December 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment and diagnosis of cancer; therapeutic pharmaceuticals for use in the treatment and diagnosis of cancer; diagnostic kits and preparations for use in the treatment and diagnosis of cancer
Goods and ServicesDiagnostic services for use in the treatment and diagnosis of cancer
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 21, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHARBINGER HEALTH, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
Party NameFlagship Labs 66, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameFlagship Labs 66, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, February 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 29, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 26, 2024ASSIGNED TO EXAMINER
Thursday, December 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023SOU EXTENSION 4 GRANTED
Tuesday, December 19, 2023SOU EXTENSION 4 FILED
Tuesday, December 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 20, 2023SOU EXTENSION 3 GRANTED
Tuesday, June 20, 2023SOU EXTENSION 3 FILED
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU EXTENSION 2 GRANTED
Tuesday, December 20, 2022SOU EXTENSION 2 FILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 21, 2022SOU EXTENSION 1 FILED
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 14, 2021NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 14, 2021EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, July 14, 2021COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Wednesday, July 14, 2021EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, July 12, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 8, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, May 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 25, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, May 25, 2021ASSIGNED TO LIE
Tuesday, May 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 25, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, May 25, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, May 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 1, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 1, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 1, 2020ASSIGNED TO EXAMINER
Wednesday, September 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

harbinger cancer diagnosis treatment pharmaceuticals research development scientific diagnostic therapeutic product